Alhemo’s expanded approval drew on explorer8, a Phase 3 study that enrolled about 150 hemophilia A or B patients, who didn't ...

The Rare Rewritten campaign hopes to change a misconception about women with X-linked disorders, columnist G Shellye Horowitz ...

Columnist Allyx Formalejo says that due to ADHD, her tendency to be hyperfocused and need to "help" is really a need for ...

Columnist Jennifer Lynne shares what it's like to be a woman living with hemophilia — things she wishes doctors would know about the disorder.

With the launch of a U.S. trial, a treatment using the B-cell medicine BE-101 has been given to a hemophilia B patient for ...

Columnist Joe MacDonald says his son Caeleb learned from living with hemophilia how important it is to always have a plan B.

Marisa Wexler is a senior science writer for Hemophilia News Today with an MS in cellular and molecular pathology. She covers the latest news and information on a variety of hemophilia topics.